The review of Julian BA et al. concluded urinary detection is more sensitive than current standard clinical testing and far less risky than renal biopsy, and so provides a useful tool for the diagnosis and monitoring of patients with IgA associated renal diseases [17]. Here, CD79A is linked to kidney disorder.